Abstract
Structure-based virtual screening of a molecular library of bioactive compounds was carried out to identify potential inhibitors against SARS-CoV-2 main protease (Mpro), an enzyme critically important for mediating viral replication and transcription. The binding affinity of these compounds to the catalytic site of the enzyme was assessed using molecular docking and molecular dynamics simulations, resulting in six molecules that exhibited high binding affinity to the SARS-CoV-2 Mpro. This is evidenced by the low values of binding free energy of the ligand/Mpro complexes comparable with those predicted using the identical computational protocols for the potent non-covalent SARS-CoV-2 Mpro inhibitor. Based on the data obtained, the identified compounds are supposed to have good therapeutic potential for inhibiting the catalytic activity of the enzyme and form promising basic structures for the development of new effective drugs against SARS-CoV-2 Mpro, an attractive target for anti-COVID-19 agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Disclosure of Interests
The authors have no competing interests to declare that are relevant to the content of this article.
References
Lu, R., et al.: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 395, 565–574 (2020). https://doi.org/10.1016/S0140-6736(20)30251-8
Chan, J.F.-W., et al.: A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 395, 514–523 (2020). https://doi.org/10.1016/S0140-6736(20)30154-9
Yan, F., Gao, F.: An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2. 2021. Comput. Struct. Biotechnol. J. 19, 4868–4883. https://doi.org/10.1016/j.csbj.2021.08.036
Ullrich, S., Nitsche, C.: The SARS-CoV-2 main protease as drug target. Bioorg. Med. Chem. Lett. 30. 127377 (2020). https://doi.org/10.1016/j.bmcl.2020.127377
Katre, S.G., et al.: Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro). Fut. J. Pharm. Sci. 8 (2022). Article no. 36. https://doi.org/10.1186/s43094-022-00423-7
Xia, S., et al.: Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant. Cell Res. 32, 404–406 (2022). https://doi.org/10.1038/s41422-022-00617-x
Xia, S., et al.: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020. V. 30. P. 343–355. https://doi.org/10.1038/s41422-020-0305-x
Tao, K., Tzou, P.L., Nouhin, J., Bonilla, H., Jagannathan, P., Shafer, R.W.: SARS-CoV-2 antiviral therapy. Clin. Microbiol. Rev. 34(4), e0010921 (2022). https://doi.org/10.1128/CMR.00109-21
Niknam Z., et al.: Potential therapeutic options for COVID-19: an update on current evidence. Eur. J. Med. Res. 27 (2022). Article no. 6. https://doi.org/10.1186/s40001-021-00626-3
Dai, W., et al.: Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science 368(6497), 1331–1335 (2020). https://doi.org/10.1126/science.abb4489
Shang, W., et al.: In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2. Antiviral Res. 208, 105450 (2022). https://doi.org/10.1016/j.antiviral.2022.105450
Zhang, Y., Ye, T., Xi, H., Juhas, M., Li, J.: Deep learning driven drug discovery: Tackling Severe Acute Respiratory Syndrome Coronavirus 2. Front. Microbiol. (2021). https://doi.org/10.3389/fmicb.2021.739684
Pillaiyar, T., Manickam, M., Namasivayam, V.M., Hayashi, Y., Jung, S.H.: An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small molecule chemotherapy. J. Med. Chem. 59, 6595–6628 (2016). doi:https://doi.org/10.1021/acs.jmedchem.5b01461
Chen, Y., Liu, Q., Guo, D.: Coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol. 92(4), 418–423 (2020). https://doi.org/10.1002/jmv.25681
Andrianov, A.M., Shuldau, M.A., Furs, K.V., Yushkevich, A.M., Tuzikov, A.V.: AI-driven de novo design and molecular modeling for discovery of small-molecule compounds as potential drug candidates targeting SARS-CoV-2 Main Protease. Int. J. Mol. Sci. 24(9), 8083 (2023). https://doi.org/10.3390/ijms24098083
Dalby, A., et al.: Description of several chemical structure file formats used by computer programs developed at Molecular Design Limited. J. Chem. Inf. Comp. Sc. 32(3), 244–255 (1992). https://doi.org/10.1021/ci00007a012
Wishart, D.S., et al.: DrugBank 5.0: a major update to the DrugBank database for 2018. Nucl. Acids Res. 46, D1074–D1082 (2017). https://doi.org/10.1093/nar/gkx1037
Sterling, T., Irwin, J.J.: ZINC 15 – Ligand discovery for everyone. J. Chem. Inf. Model. 55(11), 2324–2337 (2015). https://doi.org/10.1021/acs.jcim.5b00559
Trott, O., Olson, A.J.: AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comp. Chem. 31, 455–461 (2010). https://doi.org/10.1002/jcc.21334
Wójcikowski, M., Ballester, P., Siedlecki, P.: Performance of machine-learning scoring functions in structure-based virtual screening. Sci. Rep. 7, 46710 (2017). https://doi.org/10.1038/srep46710
Durrant, J.D., McCammon, J.A.: NNScore 2.0: a neural-network receptor–ligand scoring function. J. Chem. Inf. Model. 51(11), 2897–2903 (2011). https://doi.org/10.1021/ci2003889
Palacio-RodrÃguez, K., Lans, I., Cavasotto, C.N., Cossio, P.: Exponential consensus ranking improves the outcome in docking and receptor ensemble docking. Sci. Rep. 9(1) (2019). Article no. 1. https://doi.org/10.1038/s41598-019-41594-3
Case, D.A., et al.: AMBER 2020. University of California (2020)
Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L.: Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79(2), 926–935 (1983). https://doi.org/10.1063/1.445869
Ryckaert, J.P., Ciccotti, G., Berendsen, H.J.C.: Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23(3), 327–341 (1977). https://doi.org/10.1016/0021-9991(77)90098-5
Essmann, U., Perera, L., Berkowitz, M.L., Darden, T., Lee, H., Pedersen, L.G.: A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577–8593 (1995). https://doi.org/10.1063/1.470117
Durrant, J.D., McCammon, J.A.: BINANA: a novel algorithm for ligand-binding characterization. J. Mol. Graph. Model. 29(6), 888–893 (2011). https://doi.org/10.1016/j.jmgm.2011.01.004
Genheden, S., Ryde, U.: The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinity. Expert Opin. Drug Discov. 10(5), 449–461 (2015). https://doi.org/10.1517/17460441.2015.1032936
Zhang, C.H., et al.: Potent noncovalent inhibitors of the Main Protease of SARS-CoV-2 from molecular sculpting of the drug perampanel guided by free energy perturbation calculations. ACS Cent Sci. 7(3), 467–475 (2021). MEDLINE | ID: covidwho-1132027
Shen, C., et al.: Can machine learning consistently improve the scoring power of classical scoring functions? Insights into the role of machine learning in scoring functions. Brief. Bioinf. 22(1), 497–514 (2021). https://doi.org/10.1093/bib/bbz173
Acknowledgments
This study was funded by the Belarusian Republican Foundation for Fundamental Research (grant Ф24КИ-001) and the Alliance of National and International Science Organizations (grant ANSO-CR-PP-2021-04).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Andrianov, A.M. et al. (2024). Identification of Potential SARS-CoV-2 Main Protease Inhibitors Using Drug Repurposing and Molecular Modeling. In: Peng, W., Cai, Z., Skums, P. (eds) Bioinformatics Research and Applications. ISBRA 2024. Lecture Notes in Computer Science(), vol 14954. Springer, Singapore. https://doi.org/10.1007/978-981-97-5128-0_36
Download citation
DOI: https://doi.org/10.1007/978-981-97-5128-0_36
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-97-5127-3
Online ISBN: 978-981-97-5128-0
eBook Packages: Computer ScienceComputer Science (R0)